How IRA Would Disincentivize Rare Disease R&D – House Energy & Commerce Committee Hearing
Rep. John Joyce (R-PA), a physician, and Dr. Alexis Thompson, Chief of Division of Hematology at the Children’s Hospital of Philadelphia, discuss how the Inflation Reduction Act (IRA) will hinder innovation in the treatment of rare diseases, at a legislative hearing of the House Energy & Commerce Health Subcommittee, on June 14, 2013.
source